NeoImmuneTech Hits Limit-Up for Second Day on U.S. Biotech Deal[K-Bio Pulse]
Kort samengevat
이 기사는 2026년08월23일 08시00분에 팜이데일리 프리미엄 콘텐츠로 선공개 되었습니다. NeoImmuneTech, a South Korean developer of immuno-oncology drugs, hit its daily upper trading lim...
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij 이데일리.
Lees het volledige bericht ↗